Patents by Inventor Christopher Dahlhoff

Christopher Dahlhoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220403035
    Abstract: The present invention provides bispecific antigen-binding molecules characterized by comprising a first and a second domain, each binding to any of CS1, BCMA, CD20, CD22, FLT3, CD123, CLL1, MSLN, CDH3 or EpCAM, a third domain binding to an extracellular epitope of the human and the Macaca CD3? chain and optionally a fourth domain, which is a Fc modality. Moreover, the invention provides a polynucleotide, encoding the antigen-binding molecule, a vector comprising this polynucleotide, host cells, expressing the construct and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: November 6, 2020
    Publication date: December 22, 2022
    Inventors: Jonas Anlahr, Tara Arvedson, Julie Bailis, Matthew Chun, Igor D'Angelo, Christopher Dahlhoff, Stephanie Everts, Mattias Friedrich, Lars Gaedtke, Patrick Hoffmann, Rebecca Goldstein, Jonas Karl-Josef Honer, Roman Kischel, Matthias Klinger, Peter Kufer, Markus Muenz